A new Cedars Sinai Physician Associated Study is among the largest real-world evaluations of mandibular advancement device therapy for mild to moderate obstructive sleep apnea (OSA) and one of the first to examine a fully virtual, dentist-led care model from diagnosis through treatment and follow-up. Using the processes and care of Daybreak, the only fully at-home sleep apnea solution for the diagnosis and treatment of mild to moderate OSA, the study evaluated a dentist-led, telehealth-guided treatment pathway that included remote sleep testing, guided at-home capture of dental impressions, ongoing virtual titration, and follow-up. This is a groundbreaking study using a unique DDS-directed virtual care model of consecutive OSA patients and their outcomes. Daybreak Offers At-Home Dentist-Guided Model for Oral Appliances
“What excites me most about this study is that it demonstrates that our treatment approach at Daybreak can expand access to care while maintaining the highest clinical standards,” says Daybreak Dental Director Dr. Peter Balacky. “By standardizing the process and guiding patients through treatment remotely, the study shows that telehealth-guided mandibular advancement therapy can achieve outcomes comparable to traditional care models.”
About the Treatment Approach
Two hundred (200) patients with mild to moderate obstructive sleep apnea were treated using the Daybreak Device (a mandibular advancement device) within a standardized, telehealth-guided care system. Patients completed virtual evaluations, received a custom mandibular advancement device adjusted weekly through virtual check-ins, and underwent FDA-cleared home sleep testing before and after treatment, along with validated snoring assessments to measure outcomes.
Study Highlights
- Comparable to Traditional In-Clinic Care: Clinical outcomes were comparable to, or better than, traditional in-clinic mandibular advancement device studies, demonstrating effective dentist-directed virtual care without in-person visits.
- Large, Real-World Patient Population: The study included consecutive, unselected patients with mild-to-moderate obstructive sleep apnea, reflecting real-world clinical practice.
- Effective at Lower Mandibular Advancement: Patients saw improvement with as little as 1 to 2 mm of mandibular advancement–compared to approximately 5 mm in many previous studies–potentially supporting better tolerance and long-term adherence.
- Regulatory-Aligned Study Design: Published findings focus on mild and moderate obstructive sleep apnea, aligning with current FDA clearance.
See the full study here: https://www.cmjpublishers.com/wp-content/uploads/2025/12/evaluating-the-efficacy-of-a-virtual-health-integrated-mandibular-advancement-device-to-treat-mild-and-moderate-obstructive-sleep-apnea.pdf
Source: Daybreak
